FRA
AGN

Front Row Advisors’s Allergan plc AGN Stock Holding History

Front Row Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6
Closed -$1K – 1056
2019
Q2 		$1K Sell
6
-101
-94% -$14K ﹤0.01% 1009
2019
Q1 		$16K Hold
107
– – 0.01% 367
2018
Q4 		$14K Hold
107
– – 0.01% 353
2018
Q3 		$19 Sell
107
-15
-12% -$2.76K 0.01% 319
2018
Q2 		$22 Sell
122
-2
-2% -$321 0.01% 323
2018
Q1 		$21K Buy
124
+7
+6% +$1.17K 0.01% 327
2017
Q4 		$19K Buy
+117
New +$21K 0.02% 349

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Front Row Advisors's AGN Position: Q3 2019 in Review

Front Row Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 6 shares — an estimated $1K sold.

Front Row Advisors first reported a position in AGN in Q4 2017 and held it in 7 quarters. The position peaked at $21K in Q1 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Front Row Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Front Row Advisors sold 6 Allergan plc shares in Q3 2019, an estimated $1K.
  • Front Row Advisors first reported a position in Allergan plc in Q4 2017 and held it in 7 quarters.
  • Front Row Advisors's Allergan plc position peaked at $21K in Q1 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Front Row Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.